Isabel Teresa
Rubio
Consultora Médica
University of Texas Health Science Center at San Antonio
San Antonio, Estados UnidosPublications in collaboration with researchers from University of Texas Health Science Center at San Antonio (3)
2021
-
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age
The Lancet Oncology, Vol. 22, Núm. 4, pp. 476-488
2020
-
Standard anthracycline based versus docetaxel-capecitabine in early high clinical and/or genomic risk breast cancer in the EORTC 10041/BIG 3-04 MINDACT phase III trial
Journal of Clinical Oncology, Vol. 38, Núm. 11, pp. 1186-1197
2016
-
70-Gene signature as an aid to treatment decisions in early-stage breast cancer
New England Journal of Medicine, Vol. 375, Núm. 8, pp. 717-729